I.B. described a product still in development without overstating it.
She had hands-on medical-device experience, but the product was still in development and there were no patient outcomes to claim. We helped her describe exactly what she did and compare research and professional degree formats.
The starting point
A biomedical engineer at a small U.S. device company, applying after two years of work
Field of study
Biomedical instrumentation, human-centered testing, and translational engineering
An anonymized student journey, shared with initials.
AI-generated illustration, not a photograph of I.B.
Rejected by MIT biological engineering graduate program.
THE MATERIAL WAS ALREADY THERE
Real engineering, before any patient outcomes existed.
I.B. worked on testing fixtures, documentation, and early usability studies for a device that hadn’t yet reached the market. She understood the engineering deeply but couldn’t claim patient outcomes or commercial success. Her undergraduate research hadn’t produced a publication, and she moved between a Ph.D., product development, and entrepreneurship.
HOW WE HELPED
We helped her separate the device’s purpose, her own engineering work, and outcomes that didn’t yet exist.
Testing fixtures and documentation.
She built and documented the tools used to test a device still in development.
Early usability studies.
She took part in the first studies of how people handled the device.
A capstone and a semester in a lab.
Her undergraduate research gave her experience but no publication.
THE INTERFACE PROBLEM
An interface problem was enough; a patient outcome wasn’t needed.
Her statement focused on an interface component that engineers understood but test users handled incorrectly.
THE FIRST DRAFTS
“Improving patient care.”
It sounded natural, but it wasn’t supported for a product still in development.
→
THE PROBLEM
Users handled a component incorrectly.
Something engineers found obvious confused the people testing it.
→
THE CHANGE
An engineering revision.
The usability problem forced a design change, a real contribution that didn’t depend on patient outcomes.
LETRADO’S ROLE
We challenged implied clinical claims and helped compare degree formats. She verified the technical descriptions, wrote her materials, and got permission to discuss generalized testing work.
HOW WE WORKED TOGETHER
Preparation clarified her role and her next step.
Her small company gave her access to senior discussions, which made it easy to confuse exposure with authority.
Each project mapped by her role.
She described each project by the problem, her task, her collaborators, the evidence, and its limits.
Nothing confidential
She removed proprietary measurements and disclosed no confidential design. Her recommenders were chosen to speak to her technical ability and growth, not the company’s prestige.
Research or professional format.
She compared lab access, design courses, clinical collaboration, thesis expectations, and industry connections.
No Ph.D. promise needed
A research route could support later doctoral work, while a professional one could return her to product development sooner. She didn’t need to promise a Ph.D. to show she was serious.
A cost and time model.
She weighed the total cost and time of each program.
What a degree would add
She asked what each degree would let her do that more work experience alone would not.
Johns Hopkins joined engineering and clinical work at a lower cost.
I.B. was also admitted to Stanford’s MS in Bioengineering and Columbia’s MS in Biomedical Engineering. She chose the MSE in Biomedical Engineering at Johns Hopkins.
Engineering connected to clinical work.The link between engineering and clinical settings suited the translational work she wanted to do.
Funding that lowered the total cost.A funding arrangement reduced her total cost, without requiring an immediate commitment to a Ph.D.
